Skip to main content
Caplight Logo









Amplio Pharma BV

Amplio Pharma BV

Private
AmsterdamHealthcare & Life Scienceshttps://www.amplio-pharma.com/

Last Round

Seed

Feb 17, 2026

Est. Valuation

$9.5M

Total Funding Raised

$1.4M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Amplio Pharma BV is a pharmaceutical company developing improved versions of existing drugs intended to treat autoimmune diseases like rheumatoid arthritis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

drug reformulationsupergenericspharmacokinetics enhancerPK enhancermethotrexate enhancementautoimmune diseasesrheumatoid arthritisclinical-stage pharmadrug enhancementdrug developmentimmune-mediated inflammatory diseasesIMIDsdrug candidate

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amplio Pharma BV Comparables

Compare Amplio Pharma BV with similar companies based on industry and business-model similarity.

Amplio Pharma BV comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MAA Laboratories
73%
Elevara Medicines
72%
Halozyme Therapeutics
67%

Amplio Pharma BV Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 17, 2026

Key People

Founding team and executive leadership

Karin von Wachenfeldt

Interim CEO

Executive Team

Marguérite Mensonides Harsema

CEO and Co-founder of BV, Head of Business Development, COO and Co-founder of AB

Founding Team

Amplio Pharma BV Investors

Notable investors and investment history

Amplio Pharma BV investors
InvestorRounds
ROM InWestSeed
Innovatiefonds Noord-HollandSeed
Libertatis Ergo HoldingSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 17, 2026

    $1.4M round led by Libertatis Ergo Holding.

  • Feb 25, 2025

    Monthly visitors grew 92% MoM.

Amplio Pharma BV Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Amplio Pharma BV Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Amplio Pharma BV's valuation, stock price, and market status.

Firmographic Details

HeadquartersAmsterdam
Employee Range8
Year Founded2023
Last FundingFeb 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?